Welcome to our dedicated page for Syra Health news (Ticker: SYRA), a resource for investors and traders seeking the latest updates and insights on Syra Health stock.
Syra Health Corp. (SYRA) is a leading healthcare technology company focused on improving population health outcomes through innovative behavioral health solutions and workforce development programs. This page provides official updates and press releases directly from Syra Health, offering stakeholders timely insights into strategic initiatives.
Investors and healthcare professionals will find comprehensive coverage of SYRA's latest developments, including new contract awards, digital health product launches, and partnerships with government agencies. The curated news collection serves as a reliable resource for tracking the company's progress in mental health innovation and preventative care technologies.
All content is sourced from verified corporate communications, ensuring accuracy across updates about population health management systems, healthcare training advancements, and AI-driven behavioral health tools. Regular visitors can monitor SYRA's growing influence in addressing critical challenges like workforce shortages and health equity gaps.
Bookmark this page for streamlined access to Syra Health's evolving role in shaping healthcare delivery through science-driven solutions and measurable community impact.
Syra Health Corp. (NASDAQ: SYRA) has announced its voluntary delisting from the Nasdaq Capital Market, with the last trading day expected around April 21, 2025. The decision follows the company's non-compliance with Nasdaq's minimum $1.00 bid price requirement, which was notified on October 18, 2024.
The healthcare technology company plans to file Form 25 with the SEC around April 11, 2025. Management views this as a strategic pause to focus on strengthening core fundamentals and reducing Nasdaq-associated costs. The company expects its common stock to transition to the OTC market and intends to maintain shareholder communication, though trading continuity is not guaranteed.
Syra Health (NASDAQ: SYRA) has secured a one-year, $660,000 Population Health contract extension with a national healthcare organization, bringing the total contract value to $1.32 million over two years.
The extension involves providing Healthcare Effectiveness Data and Information Set (HEDIS®) outreach and support services, focusing on improving healthcare quality, enhancing member outcomes, and reducing costs through data analysis and member outreach initiatives.
This renewal represents a continuation of services initially announced in March 2024 and supports the expansion of Syra Health's Population Health business unit, which is identified as a key growth contributor to the company's diversifying revenue base through higher-margin business segments.
Syra Health (NASDAQ: SYRA) reported strong financial results for FY2024, with revenue reaching $8.0 million, up 45% from $5.5 million in 2023. The company's Population Health segment showed remarkable growth, with revenues more than doubling to $1.7 million, while Healthcare Workforce revenue increased 38% to $5.9 million.
Q4 2024 showed significant operational improvements, with net losses nearly halving to ($504,000) from ($995,000) in Q4 2023, and operating expenses decreasing 39% YoY. The company maintained a strong balance sheet with $2.4 million in cash and no long-term debt as of December 31, 2024.
For 2025, Syra Health projects low double-digit percentage revenue growth, driven by higher-margin Population Health and Behavioral Health units. Recent achievements include positive preliminary results from the Syrenity app clinical study and several new contract wins and extensions with government agencies.
Syra Health (NASDAQ: SYRA), a healthcare technology company, has scheduled its fourth quarter and full year 2024 financial results announcement for Tuesday, March 11, 2025, before market opening. The company will host a conference call at 9:00 a.m. ET on the same day to discuss the results.
Investors can access the conference call via webcast through the company's investor relations website. Those interested in submitting questions for the call can email them to corbin@haydenir.com. A replay of the webcast will be available in the investors section of Syra Health's website.
Syra Health Corp. (NASDAQ: SYRA) has secured a $450,000 contract extension with the Shelby County Health Department in Tennessee. This one-year extension allows Syra Health's team of epidemiologists and biostatisticians to continue their work identifying disease trends and assessing economic impacts, as initially announced in February 2024.
The project involves data analytics and the development of a public-facing dashboard providing real-time insights. With an additional one-year renewal option in 2026, the total potential contract value reaches $1.3 million over three years.
This extension represents growth in Syra Health's Population Health business unit, which the company identifies as a key driver of revenue growth. The contract aligns with Syra's strategy to diversify revenue streams across higher-margin business units. According to Dr. Deepika Vuppalanchi, Chair and CEO, the positive demand for their population health solutions demonstrates their ability to improve health outcomes while focusing on long-term revenue growth and value creation.
Syra Health (NASDAQ: SYRA) announced positive preliminary results from a clinical research study of its mental health app, Syrenity, conducted by Indiana University. The randomized study involved 135 participants with moderate or severe depression symptoms, with 63 given access to Syrenity and 72 without.
The six-week study showed promising trends in reducing depression symptoms among Syrenity users compared to non-users. Improvements were noted in cognitive reappraisal and emotion expression. The study population consisted of approximately two-thirds women, 30% racial-ethnic minorities, and 50% with bachelor's degrees or higher.
According to Dr. Lorenzo-Luaces, principal investigator, Syrenity is among less than 5% of mental health apps based on science and uniquely addresses multiple mental health conditions. A second clinical study is planned to test statistical significance, with results intended for publication in a scientific journal.
Syra Health (NASDAQ: SYRA) has secured a new $135,000, six-month contract with a Midwest university to develop behavioral health virtual training modules. The company will create up to 60-minute interactive modules focused on prevention, working alongside university committees and subject matter experts.
Additionally, Syra Health has begun implementing training for healthcare professionals in home and community-based settings through its contract with Indiana's Division of Disability and Rehabilitative Services. The combined value of these training agreements reaches $4.9 million over four years, with both contracts including two optional one-year renewals.
Syra Health (NASDAQ: SYRA) has secured two significant contracts: a new healthcare workforce contract with the Washington D.C. government valued at up to $1 million, and a $1.2 million extension to an existing contract with Indiana's NeuroDiagnostic Institute, bringing its total value to $18.7 million.
The D.C. contract, awarded on behalf of the Office of the State Superintendent of Education, involves deploying registered nurses, licensed practical nurses, and certified nursing assistants to provide healthcare services to students. This one-year agreement includes extension options and requires developing individualized service plans for students.
The expanded Indiana contract continues Syra Health's support in providing healthcare professionals to evaluate and treat patients with complex neuropsychiatric illnesses at the NeuroDiagnostic Institute. This marks Syra Health's fourth contract with the D.C. government, building on their partnership with the NeuroDiagnostic Institute that began in 2021.
Syra Health (NASDAQ: SYRA) has launched Syrenity, an AI-powered mental health app now available for adults 18+ on App Store and Google Play. The app combines cognitive behavioral therapy, mindfulness-based stress reduction, and neuroscience research to address stress, anxiety, and depression. Features include a 24/7 AI companion named Echo, personalized assessments, and real-time progress tracking.
Developed by clinical psychologists, neuroscientists, and data scientists, Syrenity offers HIPAA-compliant mental health support with advanced encryption. The app enters a global mental health app market projected to grow from $6 billion in 2023 to over $30 billion by 2033. Beyond consumer use, Syrenity is available as a B2B solution for healthcare providers, payers, and academic institutions.
Syra Health (NASDAQ: SYRA) announced its participation in the Noble Financial Capital Markets 20th Annual Equity Conference (NobleCon20) scheduled for December 3-4 in Boca Raton, Florida. CEO Dr. Deepika Vuppalanchi will present on December 3 at 2:00 p.m. ET, showcasing the company's healthcare solutions focused on mental health crisis, chronic conditions, and child welfare challenges.
The presentation will be followed by a fireside chat and one-on-one investor meetings. CFO Priya Prasad will also attend the event. The company reports strong revenue growth and expanding market presence, positioning itself to meet increasing demand for innovative healthcare solutions.
